TORONTO, Aug. 4, 2020 /PRNewswire-PRWeb/ — Join Rupa Doshi, PhD, Executive Director – Program Strategy, Oncology, Premier Research and Sameena Sharif, PhD, Senior Vice President, Product Strategy, Premier Research in a live webinar on Monday, August 24, 2020 at 11am EDT (4pm BST/UK).
Rare cancers account for 22 percent of cancer diagnoses worldwide, yet there is no universally accepted definition for a «rare» cancer. Moreover, with the evolution of genomics and associated changes in categorizing tumors, some common cancers are now characterized into groups of rare cancers, each with a unique implication for patient management and therapy.
This shifting paradigm may well underestimate the incidence of rare cancers, and further underscores the need for innovative approaches in developing new therapies. This webinar will explore the promise and challenges associated with the planning and execution of rare cancer trials including patient access, biomarker testing requirements, selecting the right endpoints, alternative study designs accounting for small sample size, and the regulatory landscape.
For more information or to register for this event, visit Novel Trial Approaches for Rare Cancer Patients.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Tel: +1 (416) 977-6555 x 352